- 1301. glycogen storage disease type VI
- [hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. ( CSP )] (UMLS (CSP) C0017925) =Disease or Syndrome =glycogen storage disease;
| - 1351. GM-CSF/GP100/IFA/MART-1/TYRP
- (UMLS (NCI) C0677812) =Therapeutic or Preventive Procedure
|
- 1302. glycogen storage disease type VII
- [autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle resulting in abnormal deposition of glycogen in muscle tissue; patients have severe congenital muscular dystrophy and are exercise intolerant. ( CSP )] (UMLS (CSP) C0017926) =Disease or Syndrome =glycogen storage disease;
| - 1352. GM-CSF/IFA/TRP-1
- (UMLS (NCI) C0677822) =Therapeutic or Preventive Procedure ;
|
- 1303. glycogen storage disease type VIII
- [x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity; symptoms are relatively mild, hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present; liver shrinkage occurs in response to glucagon. ( CSP )] (UMLS (CSP) C0017927) =Disease or Syndrome =glycogen storage disease;
| - 1353. GM-CSF/IFA/TYRP
- (UMLS (NCI) C0677819) =Therapeutic or Preventive Procedure
|
- 1304. glycogen synthase
- [An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11. ( MSH )] (UMLS (CSP) C0017932) =Amino Acid, Peptide, or Protein; Enzyme ;
=hexosyltransferase;
| - 1354. GM-CSF/IFA/VHL peptide
- (UMLS (NCI) C0796339) Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine;
=Therapeutic or Preventive Procedure |
- 1305. Glycogen Synthase Kinase 3 Alpha Gene
- [This gene is involved in carbohydrate metabolism, signal transduction and the regulation of apoptosis. ( NCI )] (UMLS (NCI) C1415320) GSK3A;
GSK3A Gene =Gene or Genome | - 1355. GM-CSF/IFN-A
- (UMLS (NCI) C0796391) Interferon Alfa/Sargramostim;
=Therapeutic or Preventive Procedure |
- 1306. Glycogen-Rich Carcinoma
- [A carcinoma characterized by the presence of malignant epithelial cells with abundant clear cytoplasm which contains glycogen. A representative example is the glycogen-rich, clear cell breast carcinoma. ( NCI )] (UMLS (NCI) C0334319) =Neoplastic Process
| - 1356. GM-CSF/IFN-A/IL-2
- (UMLS (NCI) C0796334) Interferon Alfa/Interleukin-2/Sargramostim;
=Therapeutic or Preventive Procedure |
- 1307. glycogenesis
- [formation of glycogen in organisms or living cells. ( CSP )] (UMLS (CSP) C0596623) =Molecular Function =carbohydrate biosynthesis;
glucose metabolism | - 1357. GM-CSF/IFN-A/ZDV
- (UMLS (NCI) C0338086) =Therapeutic or Preventive Procedure
|
- 1308. glycogenolysis
- [biosynthesis of glucose by hydrolysis of glycogen. ( CSP )] (UMLS (CSP) C0596624) =Molecular Function =glucose metabolism;
| - 1358. GM-CSF/IFN-G
- (UMLS (NCI) C0280713) =Therapeutic or Preventive Procedure ;
|
- 1309. Glycol, polyethylene
- [an addition polymer of ethylene oxide and water. ( CSP )] (UMLS (NCI) C0032483) =Organic Chemical; Pharmacologic Substance; Biomedical or Dental Material =Ethylene Glycols;
polyethylene;
Polymer;
[GA202] HYPEROSMOTIC LAXATIVES;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=Polyethylene Glycol 1000;
POLYETHYLENE GLYCOL 6000;
Polyethylene Glycol 8000;
POLYETHYLENE GLYCOL 300;
PEG-400;
POLYETHYLENE GLYCOL 4000;
POLYSORBATE;
Nonoxynol;
Octoxynol;
polidocanol;
(Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase;
CHOLETH-24;
tyloxapol;
Poloxamer;
OLETH-3 More… | - 1359. GM-CSF/IFN-G/IL-1B/IL-2/TNF
- (UMLS (NCI) C0392981) =Therapeutic or Preventive Procedure
|
- 1310. glycolate
- [hydroxyacetic acid or its salts or esters; an intermediate in the conversion of serine to glycine. ( CSP )] (UMLS (CSP) C0017948) =Organic Chemical =Fatty Acids, Volatile;
Hydroxy Acids =phenoxyacetate;
GLYCOLIC ACID;
| - 1360. GM-CSF/IL-11
- (UMLS (NCI) C0678045) =Therapeutic or Preventive Procedure ;
|
- 1311. glycolic aciduria
- [ ] (UMLS (CSP) C0268164) =Disease or Syndrome ;
| - 1361. GM-CSF/IL-2
- (UMLS (NCI) C0280714) =Therapeutic or Preventive Procedure ;
|
- 1312. glycolipid
- [compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol, a sphingoid, a ceramide, or a prenyl phosphate. ( CSP )] (UMLS (CSP) C0017950) =Lipid; Biologically Active Substance ;
=lipid;
=asialoganglioside;
galactolipid;
| - 1362. GM-CSF/IL-2/MOAB 14G2A
- (UMLS (NCI) C0281368) =Therapeutic or Preventive Procedure
|
- 1313. glycolipopeptide
- [ ] (UMLS (CSP) C0598532) =Amino Acid, Peptide, or Protein ;
| - 1363. GM-CSF/IL-2/MOAB 3622W94
- (UMLS (NCI) C0677997) =Therapeutic or Preventive Procedure
|
- 1314. glycolysis
- [called the Embden-Meyerhoff or glycolytic pathway in which glucose is anaerobically catabolized into the simpler compounds lactic acid or pyruvic acid, resulting in energy stored in the form of ATP. ( CSP )] (UMLS (NCI) C0017952) =Molecular Function =glucose metabolism;
=fermentation | - 1364. GM-CSF/IL-2/VBL
- (UMLS (NCI) C0677982) =Therapeutic or Preventive Procedure
|
- 1315. glycopeptide
- [peptides with covalently attached carbohydrate, usually resulting from biodegradation or laboratory hydrolysis of glycoproteins. ( CSP )] (UMLS (CSP) C0017953) =Amino Acid, Peptide, or Protein =glycoconjugate;
Peptides =BLEO;
peptidoglycan;
BLEO;
VANCOMYCIN;
| - 1365. GM-CSF/IL-6
- (UMLS (NCI) C0281625) =Therapeutic or Preventive Procedure
|
- 1316. Glycopeptide Antibiotic
- [One of a class of antibiotics originally isolated from plant and soil bacteria with structures containing either a glycosylated cyclic or polycyclic nonribosomal peptide. These antibiotics inhibit the cell wall structure of susceptible organisms (principally Gram-positive cocci) by inhibiting peptidoglycan synthesis. First-generation glycopeptide antibiotics include vancomycin, teicoplanin, and ramoplanin; second-generation semi-synthetic glycopeptide antibiotics include oritavancin, dalbavancin, and telavancin. ( NCI )] (UMLS (NCI) C0162724) =Amino Acid, Peptide, or Protein; Antibiotic ;
| - 1366. GM-CSF/IL3 Fusion Protein
- [A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines. This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells. (NCI04) ( NCI )] (UMLS (NCI) C0211169) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 1317. glycophorin
- [family of acidic integral membrane glycoproteins whose sialate groups impart a net negative charge to erythrocytes. ( CSP )] (UMLS (CSP) C0017954) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=glycoprotein;
membrane protein | - 1367. GM-CSF/L-PAM
- (UMLS (NCI) C0279312) =Therapeutic or Preventive Procedure
|
- 1318. Glycophorin A (Includes MN Blood Group) Gene
- [This gene plays a role in erythrocyte regulation. ( NCI )] (UMLS (NCI) C1367455) GYPA;
GYPA Gene =Gene or Genome | - 1368. GM-CSF/MOAB 3F8
- (UMLS (NCI) C0281630) =Therapeutic or Preventive Procedure
|
- 1319. glycoprotein
- [ubiquitous family of proteins with covalently attached oligosaccharide side chains which impart unique properties of solubility, size, antigenicity, ligand affinity, cellular targetting, and stability. ( CSP )] (UMLS (NCI) C0017968) =Amino Acid, Peptide, or Protein; Carbohydrate ;
=glycoconjugate;
gene product =Adhesion Molecule;
glycophorin;
intrinsic factor;
alpha 1 acid glycoprotein;
osteonectin;
proteoglycan;
TG;
bone sialoprotein;
apolipoprotein J;
Entactin;
Fibrillin;
MAG (myelin associated glycoprotein);
zona pellucida glycoprotein;
amyloid protein;
colony stimulating factor;
mucoprotein;
TG | - 1369. GM-CSF/MOAB R24
- (UMLS (NCI) C0280903) =Therapeutic or Preventive Procedure
|
- 1320. glycoprotein 100
- [gp 100. A tumor-specific antigen used in the development of cancer vaccines. ( NCI )] (UMLS (NCI) C0281722) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 1370. GM-CSF/NM/PCB/PRED/VCR
- (UMLS (NCI) C0280639) =Therapeutic or Preventive Procedure
|
- 1321. Glycoprotein A33 (Transmembrane) Gene
- [This gene plays a role in transcription and is a member of the immunoglobulin superfamily. ( NCI )] (UMLS (NCI) C1364020) GPA33;
GPA33 Gene =Gene or Genome | - 1371. GM-CSF/PRED/VCR
- (UMLS (NCI) C0279310) =Therapeutic or Preventive Procedure
|
- 1322. glycoprotein biosynthesis
- [anabolic formation of glycoproteins in organisms or living cells. ( CSP )] (UMLS (CSP) C0596625) =Molecular Function =protein biosynthesis;
| - 1372. GM-CSF/PXT
- (UMLS (NCI) C0280939) =Therapeutic or Preventive Procedure
|
- 1323. Glycoprotein Degradation
- [The chemical reactions and pathways resulting in the breakdown of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues other than as a moiety of nucleic acid; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. [GOC:go_curators, ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1157969) Glycoprotein Degradation Pathway =Molecular Function
| - 1373. GM-CSF/TNF
- (UMLS (NCI) C0281569) =Therapeutic or Preventive Procedure ;
|
- 1324. glycoprotein G
- [ ] (UMLS (CSP) C0599537) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1374. GM-CSF/TSPA
- (UMLS (NCI) C0214035) =Therapeutic or Preventive Procedure
|
- 1325. glycoprotein IIb IIIa receptor
- [Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid (RGD) sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA. ( MSH )] (UMLS (CSP) C0016011) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 1375. GM-CSF/ZDV
- (UMLS (NCI) C0279293) =Therapeutic or Preventive Procedure ;
|
- 1326. glycoprotein structure
- [ ] (UMLS (CSP) C0596626) =Amino Acid, Peptide, or Protein =protein structure;
| - 1376. GM2-KLH
- [A substance used to stimulate the production of antibodies that fight certain cancer cells. ( NCI )] (UMLS (NCI) C0281208) =Lipid; Pharmacologic Substance; Immunologic Factor
|
- 1327. Glycoproteins
- [Protein-bound polysaccharide from the mushroom Coriolus versicolor (Shitake); a biological response modifier with antitumor activity. ( NCI )] (UMLS (NCI) C0072522) =Carbohydrate; Pharmacologic Substance ;
| - 1377. GM2-KLH Vaccine/Interferon Alfa
- (UMLS (NCI) C0338325) =Therapeutic or Preventive Procedure ;
|
- 1328. GLYCOPYRROLATE
- [A synthetic quaternary ammonium anticholinergic agent with antimuscarinic activity. Glycopyrrolate binds to peripheral muscarinic receptors and inhibits cholinergic transmission present in the autonomic effector cells of smooth muscle, cardiac muscle, the sinoatrial node, the atrioventricular node, exocrine glands, and in the autonomic ganglia. As a result, the volume and free acidity of gastric secretions and excessive pharyngeal, tracheal, and bronchial secretions are reduced. ( NCI )] (UMLS (NCI) C0017970) =Organic Chemical; Pharmacologic Substance ;
=ammonium compound;
parasympatholytic agent;
Pyrrolidines;
=GLYCOPYRROLATE 0.2 MG/ML;
GLYCOPYRROLATE 1 MG;
GLYCOPYRROLATE 2 MG | - 1378. GM2-KLH Vaccine/QS21
- [A cancer vaccine based on the immunogenic ganglioside GM2, The GM2-KLH Vaccine/QS21 vaccine consists of GM2 conjugated with KLH keyhole limpet hemocyanin (KLH), a potent immunostimulant, and is admixed with the adjuvant QS21, a saponin fraction extracted from the bark of the South American tree Quillaja saponaria Molina. GM2 is a cell surface carbohydrate antigen expressed by most melanoma cells and various other tumor cell types. (NCI04) ( NCI )] (UMLS (NCI) C0338324) =Therapeutic or Preventive Procedure ;
|
- 1329. glycosidase
- [covering the sugar hydrolases. ( CSP )] (UMLS (CSP) C0017976) =Amino Acid, Peptide, or Protein; Enzyme ;
=hydrolase;
=N glycosidase;
O glycosidase;
amylase;
Cellulase;
Galactosidases;
Glucosidases;
chondroitinase | - 1379. GMP
- [guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. ( CSP )] (UMLS (CSP) C0520462) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=guanine nucleotide;
=cGMP |
- 1330. Glycoside
- [any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. ( CSP )] (UMLS (NCI) C0017977) =Carbohydrate =carbohydrate;
=Aminoglycoside Agents;
macrolide antibiotic;
cardiac glycoside;
digitonin;
galactoside;
Aureolic acid;
NOVOBIOCIN;
VANCOMYCIN;
riboside;
terpene saponin;
glucuronide;
[AM300] AMINOGLYCOSIDES;
macrolide antibiotic;
Bioflavonoid;
cardiac glycoside;
Glucosides;
LINCOMYCIN;
NOVOBIOCIN;
nucleoside;
nucleotide;
TANNIC ACID | - 1380. GNA12
- [This gene plays a role in signal transduction and cytoskeletal remodeling. ( NCI )] (UMLS (NCI) C1333684) GNA12 Gene;
Guanine Nucleotide Binding Protein (G Protein) Alpha 12 Gene;
=Gene or Genome |
- 1331. glycosphingolipidoses
- [ ] (UMLS (CSP) C0599458) =Disease or Syndrome
| - 1381. GNA12
- [Encoded by human GNA12 Gene (G-Alpha 4 (G(12)) Family), 380-aa 44-kDa membrane-bound Guanine Nucleotide Binding Protein Alpha 12 is a G protein alpha subunit that contains a guanine nucleotide binding site and is involved in transmembrane signaling. (NCI) ( NCI )] (UMLS (NCI) C1333882) G-Protein Alpha Subunit 12;
Guanine Nucleotide Binding Protein Alpha 12 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 1332. glycosuria
- [presence of glucose in the urine, especially the excretion of an abnormally large amount of sugar (glucose) in the urine. ( CSP )] (UMLS (CSP) C0017979) =Finding ;
=Metabolic Disease;
Clinical Finding =DIABETES RENALA | - 1382. GNAI1
- [This gene is plays a role in signal transduction and is involved in neurotransmission. ( NCI )] (UMLS (NCI) C1415142) GNAI1 Gene;
Guanine Nucleotide Binding Protein (G Protein), Alpha Inhibiting Activity Polypeptide 1 Gene =Gene or Genome |
- 1333. glycosylated crystallin
- [ ] (UMLS (CSP) C0598252) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1383. GNAI2
- [This gene plays a role in signal transduction and neurotransmission. ( NCI )] (UMLS (NCI) C1366857) GNAI2 Gene;
Guanine Nucleotide Binding Protein (G Protein), Alpha Inhibiting Activity Polypeptide 2 Gene =Gene or Genome |
- 1334. glycosylated hemoglobin
- [ ] (UMLS (CSP) C0017853) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1384. GNAI3
- [This gene is involved in signal transduction and neurotransmission. ( NCI )] (UMLS (NCI) C1415144) GNAI3 Gene;
Guanine Nucleotide Binding Protein (G Protein), Alpha Inhibiting Activity Polypeptide 3 Gene =Gene or Genome |
- 1335. Glycosylated Hemoglobin Measurement
- [A measurement of the glycosylated hemoglobin in a biological specimen. ( NCI )] (UMLS (NCI) C0202054) =Laboratory Procedure
| - 1385. GNAQ
- [This gene plays a role in signal transduction and is involved in calcium signaling. ( NCI )] (UMLS (NCI) C1333685) GNAQ Gene;
Guanine Nucleotide Binding Protein (G Protein), Q Polypeptide Gene;
=Gene or Genome |
- 1336. Glycosylated Recombinant G-CSF
- [A glycosylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. ( NCI )] (UMLS (NCI) C0218640) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 1386. GNAS
- [This gene plays a role in signal transduction and is associated with pituitary tumors. ( NCI )] (UMLS (NCI) C1366550) GNAS Complex Locus Gene;
GNAS Gene =Gene or Genome |
- 1337. Glycosylation
- [chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. ( CSP )] (UMLS (NCI) C0017982) =Natural Phenomenon or Process ;
=chemical reaction;
=ADP ribosylation;
glycation;
| - 1387. GNATHOSTOMIASIS
- (UMLS (ICD9CM) C0018013) =Disease or Syndrome ;
|
- 1338. Glycosylation
- [The covalent chemical or post-translational biochemical addition of carbohydrate or glycosyl groups to peptides or proteins by glycosyl transferases. ( NCI )] (UMLS (NCI) C0376322) =Natural Phenomenon or Process
| - 1388. GNAZ
- [This gene plays a role in signal transduction. It is putatively involved in regulation of the ionic balance of perilymphatic and endolymphatic cochlear fluids. ( NCI )] (UMLS (NCI) C1333686) GNAZ Gene;
Guanine Nucleotide Binding Protein (G Protein), Alpha Z Polypeptide Gene;
=Gene or Genome |
- 1339. Glycosylation-Inhibiting Factor
- [This protein is a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation. It plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. (from Locuslink) ( NCI )] (UMLS (NCI) C0312359) =Amino Acid, Peptide, or Protein; Enzyme
| - 1389. GNAZ
- [Guanine nucleotide binding protein is a member of a G protein subfamily that mediates signal transduction; component of pertussis toxin-insensitive (PTX) heterotrimeric G-protein complexes. The protein differs strikingly from other G-alpha subunits in amino acid sequence in a number of regions, and it appeared to be highly enriched in neural tissue. (LocusLink and OMIM) ( NCI )] (UMLS (NCI) C1333883) Guanine Nucleotide Binding Protein Alpha Z;
Guanine Nucleotide Binding Protein Alpha Z Polypeptide =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 1340. glycosylphosphatidylinositol
- [compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols; they act to anchor proteins or polysaccharides to cell membranes. ( CSP )] (UMLS (CSP) C0061688) =Organophosphorus Compound; Lipid; Biologically Active Substance =phosphatidylinositol;
| - 1390. GNB
- [A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal. (NCI) ( NCI )] (UMLS (NCI) C0018387) =Geographic Area
|
- 1341. Glycosyltransferase Gene
- [Genes that encode the class of enzymes that catalyze the transfer of glycosyl groups to an acceptor; often another carbohydrate molecule, a protein, or inorganic phosphate. Some enzymes in this class catalyze hydrolysis - the transfer of a glycosyl group to water. Subclasses include Hexosyltransferases, Pentosyltransferases, and Sialyltransferases. (NCI) ( NCI )] (UMLS (NCI) C1333828) =Gene or Genome ;
| - 1391. GNB1
- [This gene is involved in signal transduction and negative regulation of synaptic transmission. ( NCI )] (UMLS (NCI) C1333687) GNB1 Gene;
Guanine Nucleotide Binding Protein (G Protein), Beta Polypeptide 1 Gene;
=Gene or Genome |
- 1342. Glycyclamide
- (UMLS (NCI) C0076794) =Organic Chemical; Pharmacologic Substance
| - 1392. GNB2
- [This gene plays a role in signal transduction and is involved in the suppression of glucocorticoid-responsive gene activation. ( NCI )] (UMLS (NCI) C1333688) GNB2 Gene;
Guanine Nucleotide Binding Protein (G Protein), Beta Polypeptide 2 Gene;
=Gene or Genome |
- 1343. glyoxal
- [yellow crystalline compound prepared by the oxidation of acetaldehyde. ( CSP )] (UMLS (CSP) C0017992) =Organic Chemical; Pharmacologic Substance =aldehyde;
| - 1393. GNB3
- [This gene is plays a role in signal transduction. It is associated with both hypertension and obesity. ( NCI )] (UMLS (NCI) C1333689) GNB3 Gene;
Guanine Nucleotide Binding Protein (G Protein), Beta Polypeptide 3 Gene;
=Gene or Genome |
- 1344. glyoxalase
- [An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5. ( MSH )] (UMLS (CSP) C0022956) =Amino Acid, Peptide, or Protein; Enzyme
| - 1394. Gnosis
- (UMLS (HL7) C1552049) =Idea or Concept =Religious Affiliation;
|
- 1345. glyoxylate
- [ ] (UMLS (CSP) C0017996) =Organic Chemical ;
=Acids, Aldehydic;
=Oxamic Acid | - 1395. gnotobiotic
- [ ] (UMLS (CSP) C0018014) =Occupation or Discipline ;
|
- 1346. Glyzophrol
- (UMLS (NCI) C0728924) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 1396. GNRH1
- [This gene is involved in female reproductive regulation and intercellular communication. ( NCI )] (UMLS (NCI) C1415169) GNRH1 Gene;
Gonadotropin-Releasing Hormone 1 (Luteinizing-Releasing Hormone) Gene =Gene or Genome |
- 1347. GM-CSF plasmid DNA melanoma vaccine
- [A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine. ( NCI )] (UMLS (NCI) C0393071) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 1397. GNRH2
- [This gene plays a role in female reproductive regulation. ( NCI )] (UMLS (NCI) C1415170) GNRH2 Gene;
Gonadotropin-Releasing Hormone 2 Gene =Gene or Genome |
- 1348. GM-CSF plasmid DNA pancreatic tumor cell vaccine
- [A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0677758) =Pharmacologic Substance; Immunologic Factor ;
| - 1398. GNRHR
- [This gene plays a role in the activation of the phosphatidylinositol-calcium second messenger signal transduction pathway. ( NCI )] (UMLS (NCI) C1415171) GNRHR Gene;
Gonadotropin-Releasing Hormone Receptor Gene =Gene or Genome |
- 1349. GM-CSF plasmid DNA sarcoma vaccine
- [An autologous sarcoma cell vaccine with potential immunostimulatory activity. Tumor cells harvested from a patient with sarcoma are transfected with a plasmid DNA encoding for human sargramostim (GM-CSF) using a particle-mediated gene transfer (PMGT) technique, which avoids the use infectious components. Vaccination with an autologous sargramostim sarcoma vaccine produces high levels of GM-CSF, a cytokine that enhances antigen presentation by activated macrophages and increases the recognition of weakly immunogenic tumors by cytotoxic T-lymphocytes. ( NCI )] (UMLS (NCI) C0393070) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 1399. Goal
- [Expectation to make a specific observation with a desired value at a predefined future time ( HL7V3.0 )] (UMLS (HL7) C1571704) =Idea or Concept; ;
=ActMoodPredicate;
|
- 1350. GM-CSF/gp100/IFA
- (UMLS (NCI) C0677818) =Therapeutic or Preventive Procedure
| - 1400. goal directed behavior
- [ ] (UMLS (CSP) C1537018) =Idea or Concept
|
home
